TestoQuench™ for Men is a unique formulation that is designed to restore and support healthy prostate function by decreasing testosterone production, decreasing conversion of testosterone to dihydrotestosterone (DHT), preventing testosterone and other androgens from binding to androgen receptors, and protecting the prostate by various mechanisms. This is possible because of the synergy that exists when multiple anti-androgen herbs are used together in effective dosages.
All of the herbs have documented antiandrogenic, anti-inflammatory, antiproliferative and analgesic properties that decrease androgen stimulation, inflammation, proliferation and discomfort in the prostate.
In addition to the universal documented antiandrogenic, anti-inflammatory, antiproliferative and analgesic properties, three of the herbs are effective androgen receptor antagonists, which prevent any remaining testosterone form binding to cells throughout the body. Four of the herbs are effective 5-alpha-reductase inhibitors, which prevent any residual testosterone from being converted to the more potent dihydrotestosterone (DHT). Most of the herbs have antioxidant properties, which is important for prostate health. Serenoa repens can also decrease prolactin induced prostate hyperplasia. Ocimum sanctum decreases testosterone production.
Synergy comes from the Greek word synergos - συνεργός - meaning “working together”.
The synergy of TestoQuench™ for Men is grounded in the fact that it is a Hormone Specific Formulation™, designed to specifically and aggressively address the unique problems associated with androgen hypersensitivity in prostate tissue. The combination of synergy and high potency herbs can effectively decrease androgen hypersensitivity by decreasing conversion of testosterone to dihydrotestosterone (DHT).
The full dosage can suppress testosterone and androgen production function to the point that sexual function can diminish due to androgen deprivation. Once prostate health has been restored, the formulation can be weaned if desired. The androgen deprivation will diminish two weeks after the formulation is stopped.